Welcome to LookChem.com Sign In|Join Free
  • or
Benzenesulfonamide, N-(4-chlorophenyl)-2-methyl-5-nitro- is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

87316-94-7

Post Buying Request

87316-94-7 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

87316-94-7 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 87316-94-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,7,3,1 and 6 respectively; the second part has 2 digits, 9 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 87316-94:
(7*8)+(6*7)+(5*3)+(4*1)+(3*6)+(2*9)+(1*4)=157
157 % 10 = 7
So 87316-94-7 is a valid CAS Registry Number.

87316-94-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name N-(4-chlorophenyl)-2-methyl-5-nitrobenzenesulfonamide

1.2 Other means of identification

Product number -
Other names 4-nitro-toluene-2-sulfonic acid-(4-chloro-anilide)

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:87316-94-7 SDS

87316-94-7Downstream Products

87316-94-7Relevant academic research and scientific papers

THERAPEUTIC COMPOUNDS AND COMPOSITIONS

-

Page/Page column 67; 68; 183, (2014/05/07)

Provided are aryl sulfonamide diarylurea derivative compounds that are inhibitors of mutant isocitrate dehydrogenase 1/2 (IDH 1/2), useful for treating cancer. Also provided are methods of treating cancer comprising administering to a subject in need thereof a compound described herein. Cancers that are treatable by the compounds of the invention are glioblastoma, myelodysplastic syndrome, myeloproliferative neoplasm, acute myelogenous leukemia, sarcoma, melanoma, non-small cell lung cancer, chondrosarcoma, and non-Hodgkin's lymphoma (NHL).

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 87316-94-7